Maruyama Y - Search Results

1

Relationship between the -374T/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis.

Maruyama Y, Numata M, Nakayama M, Matsuo N, Nordfors L, Hosoya T, Lindholm B. Maruyama Y, et al. Ther Apher Dial. 2007 Aug;11(4):301-5. doi: 10.1111/j.1744-9987.2007.00473.x. Ther Apher Dial. 2007. PMID: 17661837

2

Association of Graves' disease with Evans' syndrome in a patient with IgA nephropathy.

Ikeda K, Maruyama Y, Yokoyama M, Kato N, Yamanoto H, Kaguchi Y, Nakayama M, Shimada T, Tojo K, Kawamura T, Hosoya T. Ikeda K, et al. Among authors: maruyama y. Intern Med. 2001 Oct;40(10):1004-10. doi: 10.2169/internalmedicine.40.1004. Intern Med. 2001. PMID: 11688823 Free article.

3

Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration.

Nakayama M, Yoshimura K, Maruyama Y, Numata M, Hosoya T, Izumi G. Nakayama M, et al. Among authors: maruyama y. Nephrol Dial Transplant. 2004 Jun;19(6):1664-5. doi: 10.1093/ndt/gfh198. Nephrol Dial Transplant. 2004. PMID: 15150373 No abstract available.

4

Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.

Maruyama Y, Lindholm B, Stenvinkel P. Maruyama Y, et al. J Nephrol. 2004 Nov-Dec;17 Suppl 8:S72-6. J Nephrol. 2004. PMID: 15599890 Review.

5

Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients.

Maruyama Y, Stenvinkel P, Lindholm B. Maruyama Y, et al. Blood Purif. 2005;23(4):275-81. doi: 10.1159/000086012. Epub 2005 May 30. Blood Purif. 2005. PMID: 15925866 Review.

6

Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, Yamamoto H, Yokoyama K, Kawaguchi Y, Matsushima M. Yamamoto R, et al. Among authors: maruyama y. Clin Exp Nephrol. 2005 Jun;9(2):148-52. doi: 10.1007/s10157-005-0349-8. Clin Exp Nephrol. 2005. PMID: 15980950

7

[Peritoneal injury and vasculopathy in peritoneal dialysis].

Maruyama Y, Nakayama M. Maruyama Y, et al. Nihon Rinsho. 2005 Jun;63 Suppl 6:430-3. Nihon Rinsho. 2005. PMID: 15999747 Review. Japanese. No abstract available.

8

Encapsulating peritoneal sclerosis is a separate entity: Con.

Nakayama M, Maruyama Y, Numata M. Nakayama M, et al. Among authors: maruyama y. Perit Dial Int. 2005 Feb;25 Suppl 3:S107-9. Perit Dial Int. 2005. PMID: 16048271

9

Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease.

Maruyama Y, Nordfors L, Stenvinkel P, Heimburger O, Bárány P, Pecoits-Filho R, Axelsson J, Hoff CM, Holmes CJ, Schalling M, Lindholm B. Maruyama Y, et al. Blood Purif. 2005;23(5):384-93. doi: 10.1159/000087196. Epub 2005 Jul 27. Blood Purif. 2005. PMID: 16088107

10

Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients.

Sherif AM, Nakayama M, Maruyama Y, Yoshida H, Yamamoto H, Yokoyama K, Kawakami M. Sherif AM, et al. Among authors: maruyama y. Nephrol Dial Transplant. 2006 Jun;21(6):1675-81. doi: 10.1093/ndt/gfl054. Epub 2006 Mar 22. Nephrol Dial Transplant. 2006. PMID: 16554330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,416 results

Search Page

Filters